FRIDAY, April 17, 2026 The U.S. Food and Drug Administration (FDA) will soon review whether certain peptides should be allowed in customized medications made by
FDA To Review Whether To Allow More Access To Certain Peptides MedNews
Latest from Blog
How Long Will I Live? This At-Home Fitness Challenge Can Help You Know
This sitting-to-standing assessment is an accurate life expectancy test, according to a recent study. Post Views: 0
Another roadblock for DOJ campaign against trans health
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good morning and happy Thursday. Let’s get right to it. Read the rest… Post
STAT+: Facing a brutal run, battered vaccine makers still see cause for hope
SAN DIEGO — It is an unusual time to be in the vaccine business. But in the view of those gathered here at the BIO international conference this week, it’s not altogether
Bipartisan bill seeks to allow direct prescribing of methadone for opioid addiction
Two senators are renewing their push to greatly expand access to methadone treatment for opioid addiction. On Thursday, Sens. Ed Markey (D-Mass.) and Rand Paul (R-Ky.) are introducing an updated version of
Jubilant HollisterStier gets FDA warning letter for quality control problems
Jubilant HollisterStier, a CDMO unit of India’s Jubilant Pharmova, earned an FDA warning letter after inspectors found its Montreal production plant lacked appropriate quality control systems. Post Views: 0